“Christoph Benn, director of resource mobilization and donor relations at the Global Fund to Fight AIDS, Tuberculosis and Malaria, updated global health community advocates Wednesday on … the multilateral organization,” the Center for Global Health Policy’s “Science Speaks” blog reports. Benn spoke about staffing changes at the Fund, the organizations’ new risk management framework and the Transitional Funding Mechanism (TFM), and the Obama Administration’s proposed FY 2013 budget request, according to the blog (Mazzotta, 4/4).
Funding Shortfalls Could Hinder Implementation Of Treatment As Prevention Strategies, Al Jazeera Reports
Al Jazeera examines the administration of combination antiretroviral therapy (ART) worldwide, focusing on treatment as prevention (TasP), but says current funding levels are insufficient to implement the strategy. The HPTN 052 study showed that HIV-positive people who take ART could reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, according to the news agency. “This research is considered a game changer,” Al Jazeera writes, noting, “2012 may not be the year the international community eliminates HIV, but health experts say it could still be the year where the tide is turned.” The article includes comments from several HIV/AIDS experts (Dalal, 3/31).
According to a study recently published in a special supplement of the Journal of Infectious Diseases, half of countries receiving grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria provide tuberculosis (TB) services in prisons; “even when TB services were provided to prisoners, they were limited in scope; and “[f]ew of the programs receiving a grant from the Global Fund offered services dedicated to the treatment and prevention of multi-drug resistant TB (MDR-TB),” an aidsmap news story reports. TB is a leading cause of death among incarcerated individuals worldwide, aidsmap notes. The study authors concluded, “There is an urgent need to better understand the financing needs and cost-effective service delivery models for tuberculosis care in prisons,” according to the story (Carter, 3/30).
Gabriel Jaramillo, general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, “has given an interview [.pdf] with the Spanish newspaper El Mundo, in which he outlines the direction and achievements to-date in making the Global Fund a more efficient and successful organization,” according to a Global Fund press release. In the interview, Jaramillo “also stresses the importance of continuing the work of the Global Fund in saving lives through greatly improving the grant management processes and strengthening this function inside the organization,” the press release states (3/28).
VOA News reports on a March 20 panel meeting in Washington, D.C., that highlighted the contributions of corporations and non-governmental organizations (NGOs) to the Global Fund to Fight AIDS, Tuberculosis and Malaria. Chevron, which has “invested $30 million for the three-year period between 2008 and 2011 and has pledged another $25 million through 2013,” was recognized at the meeting as “the first Global Fund Corporate Champion,” according to VOA (DeCapua, 3/23).
NGOs Release Joint Statement Calling For Governments To Increase Payments To Global Fund To Fill Gap In TB Funding
Ahead of World Tuberculosis (TB) Day on March 24, three non-governmental organizations (NGOs) released a joint statement warning that “[a] $1.7 billion funding shortfall to fight [TB] over the next five years means 3.4 million patients will go untreated and gains made against the disease will be reversed,” Reuters reports. The International HIV/AIDS Alliance, the Stop AIDS Campaign and Results UK said in the statement that the cancellation of Round 11 grants from the Global Fund to Fight AIDS, Tuberculosis and Malaria was endangering the expansion of treatment and prevention programs, the news agency notes. The statement “called on governments to scale up funding of TB, HIV and malaria programs at a G20 meeting in Mexico in June in an effort to replenish the Global Fund with $2 billion,” according to Reuters (Mollins, 3/23).
Swazi, South African Activists March To U.S. Consulate In Johannesburg To Call For Emergency Global Fund Meeting
“Almost a thousand Swazi and South African HIV activists marched to the United States consulate in Johannesburg on [Thursday] to demand that the U.S. continue supporting the Global Fund to Fight AIDS, Tuberculosis (TB) and Malaria, and safeguard funding of its President’s Emergency Plan for AIDS Relief (PEPFAR),” PlusNews reports. “The march organizers — a coalition of international and regional HIV organizations, including the global medical charity Medecins Sans Frontieres (MSF), the World AIDS Campaign, and the AIDS Rights Alliance Southern Africa — also called on the British and Australian governments to join their American counterparts in kick-starting a response to solve the Global Fund’s financial crisis,” according to the news service.
“At a public event [held Tuesday] on Capitol Hill, the Global Fund to Fight AIDS, Tuberculosis and Malaria and Friends of the Global Fight Against AIDS, Tuberculosis and Malaria spotlighted the contributions of public-private partnerships to the Global Fund’s lifesaving work,” a joint press release (.pdf) reports. The event highlighted the “unique and essential roles” that partners like Chevron, the Coca-Cola Company, (RED) and PEPFAR play in improving lives around the globe, “[f]rom assistance in drug delivery, to supplying much-needed resources, to mobilizing consumer markets, to in-country partnerships,” according to the press release. “The partners highlighted at the Capitol Hill event have not only provided funding, but have also brought their individual expertise to the Global Fund, sharing their knowledge and building bridges between the public, private and health sectors,” the press release states (3/20).
A new report, titled “Injection Drug Use in Ukraine” and published by the Center for Strategic & International Studies (CSIS), examines the challenges of providing HIV prevention and care services in the country, particularly to people who inject drugs (PWID), who accounted for “nearly 50 percent of new HIV infections registered in 2010,” according to the CSIS website. Authors Phillip Nieburg, senior associate and co-chair of the Prevention Committee of the CSIS HIV/AIDS Task Force, and Lisa Carty, senior adviser in the CSIS Global Health Policy Center, also examine how the Global Fund to Fight AIDS, Tuberculosis and Malaria and PEPFAR could help Ukraine “in advancing HIV prevention and other services for PWID,” the website notes (3/16).
Japan on Monday provided a $340 million contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria, “the highest amount that Japan has ever made in 10 years of vigorous support for the Global Fund,” according to a fund press release. “This new contribution represents a significant increase over Japan’s previous highest contribution of $246 million in 2010” and “raises Japan’s contributions to the Global Fund to more than $1.6 billion since its creation in 2002,” the press release states (3/13).